Please Read Full Prescribing Information, Including Boxed WARNINGS, And Medication Guide. Additional Information Can Be Found At Www.brilintatouchpoints.com. (Photo: AstraZeneca)
AstraZeneca (NYSE: AZN) today introduced Complete the Course, a creative education program to support patients taking BRILINTA ® (ticagrelor). Patients who enroll in the Complete the Course program receive support services across multiple channels to help them stay on their full course of BRILINTA therapy. One important support resource now available is Access My BRILINTA, which provides time-saving prescription access and affordability information to patients and healthcare providers.
Complete the Course was created specifically to address patient preference for how they receive information about their medication as they transition from hospital to home. A recent nationwide patient survey showed that patients with ACS value robust, multi-channel communication to learn more about the medication prescribed. The survey was sponsored by AstraZeneca and conducted by Ipsos Public Affairs.
“Cardiologists have a tremendous responsibility to not only provide the best possible care for their patients, but also to ensure that their patients receive complete information about their diagnosis and the importance of adherence to treatment,” stated James Ferguson, MD, Executive Director, Medical Affairs and Strategic Development, and Vice President for Global Medical Affairs. “With the combination of the BRILINTA Complete the Course program along with Access My BRILINTA, we are now able to provide a variety of resources to patients with ACS and healthcare providers to help ensure continuity and optimal delivery of care throughout the course of treatment.”
A nationwide patient survey was conducted in 201 patients with ACS. The patients with ACS were adults aged 60 years and older who have suffered a heart attack or have been diagnosed with ACS (including heart attack and chest pain), and have been prescribed some form of medication for treatment of their heart attack.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
